Oramed & Scilex amend note: $2M prepayment, warrant exercise, liquidity waiver

ORAMED PHARMACEUTICALS INC.

Scilex pays Oramed $2M Sept 23: $1.7M to March 2025 amort, $300K buys back 4M $11.50 warrants.
Oramed can immediately exercise CS-5 Warrant for up to 1,062,500 Scilex shares; remaining half exercisable on original date.
Minimum Liquidity covenant under Note reduced to $0 from Sept 19, 2024 until Maturity (March 21, 2025).
$20M amortization payment due Sept 23, 2024 extended to Sept 30, 2024 without default.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.